Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Shinozaki · SciRah

Researcher profile · Semantic Scholar

K. Shinozaki

Share profile

K. Shinozaki — researcher profile on SciRah

h-index: 26
Works: 113
Citations: 3,102

Most-cited papers

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
K. Yamazaki, M. Nagase, H. Tamagawa, S. Ueda +44 more
2016Annals of Oncology216 citations Open access
Semantic Scholar
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
A. Makiyama, Y. Sukawa, T. Kashiwada, J. Kawada +18 more
2020Journal of Clinical Oncology168 citations
Semantic Scholar
Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer.
N. Katakami, T. Harada, T. Murata, K. Shinozaki +6 more
2017Journal of Clinical Oncology123 citations
Semantic Scholar
Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice
O. Ebert, S. Harbaran, K. Shinozaki, S. Woo
2005Cancer Gene Therapy117 citations Open access
Semantic Scholar
rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
Lan Wu, Tian-Gui Huang, M. Meseck, J. Altomonte +6 more
2008Human Gene Therapy80 citations Open access
Semantic Scholar
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
K. Shitara, T. Yamanaka, T. Denda, Y. Tsuji +14 more
2019Annals of Oncology71 citations Open access
Semantic Scholar
Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV
K. Shinozaki, O. Ebert, S. Woo
2005Hepatology64 citations Open access
Semantic Scholar
Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer.
N. Katakami, K. Oda, K. Tauchi, K. Nakata +5 more
2017Journal of Clinical Oncology58 citations
Semantic Scholar
Prophylactic Alpha Interferon Treatment Increases the Therapeutic Index of Oncolytic Vesicular Stomatitis Virus Virotherapy for Advanced Hepatocellular Carcinoma in Immune-Competent Rats
K. Shinozaki, O. Ebert, A. Suriawinata, S. Thung +1 more
2005Journal of Virology49 citations Open access
Semantic Scholar
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
M. Ryu, E. Baba, K. Lee, Y. Park +16 more
2015Annals of Oncology46 citations Open access
Semantic Scholar
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)
T. Nakajima, K. Yamaguchi, N. Boku, I. Hyodo +10 more
2020Gastric Cancer42 citations Open access
Semantic Scholar
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)
Y. Miura, Y. Sukawa, S. Hironaka, Misuzu Mori +25 more
2017Gastric Cancer42 citations Open access
Semantic Scholar
Efficient infection of tumor endothelial cells by a capsid-modified adenovirus
K. Shinozaki, E. Suominen, F. Carrick, B. Sauter +4 more
2006Gene Therapy38 citations Open access
Semantic Scholar
A randomized phase II study of weekly paclitaxel ± trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum: WJOG7112G (T-ACT).
A. Makiyama, K. Sagara, J. Kawada, T. Kashiwada +16 more
201835 citations
Semantic Scholar
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
W. Ichikawa, Keisuke Uehara, K. Minamimura, C. Tanaka +16 more
2015British Journal of Cancer35 citations Open access
Semantic Scholar
Treatment of multi‐focal colorectal carcinoma metastatic to the liver of immune‐competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus
K. Shinozaki, O. Ebert, S. Woo
2005International Journal of Cancer35 citations Open access
Semantic Scholar
Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B
S. Yuki, K. Shinozaki, T. Kashiwada, T. Kusumoto +14 more
2019Cancer Chemotherapy and Pharmacology27 citations
Semantic Scholar
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
M. Kotaka, T. Yoshino, K. Oba, K. Shinozaki +11 more
2015Cancer Chemotherapy and Pharmacology27 citations Open access
Semantic Scholar
Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth
T. Kubo, S. Shimose, Toshihiro Matsuo, J. Fujimori +5 more
2011Journal of Orthopaedic Research26 citations
Semantic Scholar
JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer
T. Yoshino, M. Kotaka, K. Shinozaki, T. Touyama +15 more
2019Cancer Chemotherapy and Pharmacology23 citations Open access
Semantic Scholar
A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
T. Kosugi, Sasagu Hamada, C. Takigawa, K. Shinozaki +9 more
2014Journal of Pain and Symptom Management23 citations Open access
Semantic Scholar
The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer.
M. Yamaki, K. Shinozaki, T. Sakaguchi, M. Meseck +3 more
2013International Journal of Molecular Medicine22 citations Open access
Semantic Scholar
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G).
D. Sakai, H. Taniguchi, N. Sugimoto, T. Tamura +35 more
2020European Journal of Cancer19 citations
Semantic Scholar
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy
M. Kotaka, Y. Saito, Takeshi Kato, H. Satake +15 more
2020Cancer Chemotherapy and Pharmacology18 citations Open access
Semantic Scholar
Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy
M. Doi, Yohei Okamoto, M. Yamauchi, H. Naitou +1 more
2012International Journal of Clinical Oncology17 citations
Semantic Scholar
Poor association between dihydropyrimidine dehydrogenase ( DPYD ) genotype and fluoropyrimidine‐induced toxicity in an Asian population
M. Kanai, T. Kawaguchi, M. Kotaka, D. Manaka +16 more
2022Cancer Medicine14 citations Open access
Semantic Scholar
Sinusoidal obstruction syndrome post-treatment with trastuzumab emtansine (T-DM1) in advanced breast cancer
Yasutoshi Fujii, M. Doi, Naofumi Tsukiyama, Yui Hattori +7 more
2019International Cancer Conference Journal13 citations Open access
Semantic Scholar
REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan—Biomarker analysis.
Y. Tsuji, K. Shitara, T. Yamanaka, T. Denda +14 more
201813 citations
Semantic Scholar
Capecitabine Plus Bevacizumab for Cardiac Metastasis of Sigmoid Colon Cancer: Case Report and Literature Review
Sawako Hiroi, M. Miguchi, S. Ikeda, H. Nakahara +4 more
2020In Vivo9 citations Open access
Semantic Scholar
Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cub
T. Nagasaka, H. Mishima, A. Sawaki, M. Shimokawa +8 more
2016BMJ Open9 citations Open access
Semantic Scholar
Large-Scale Prospective Genome-Wide Association Study of Oxaliplatin in Stage II/III Colon Cancer and Neuropathy.
M. Kanai, T. Kawaguchi, M. Kotaka, D. Manaka +16 more
2021Annals of Oncology8 citations Open access
Semantic Scholar
A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)
K. Shinozaki, Takeshi Yamada, J. Nasu, Toshihiko Matsumoto +16 more
2020International Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Treatment outcomes according to the macroscopic tumor type in locally advanced esophageal squamous cell carcinoma treated by chemoradiotherapy
K. Kubo, K. Wadasaki, K. Shinozaki
2019Japanese Journal of Radiology7 citations
Semantic Scholar
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Takahiko Ito, A. Takashima, K. Yamazaki, H. Yukami +22 more
2022International Journal of Clinical Oncology6 citations
Semantic Scholar
Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case
Ryosuke Arata, T. Itamoto, S. Ikeda, H. Nakahara +3 more
2016Surgery Case Reports6 citations Open access
Semantic Scholar
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats.
J. Altomonte, Kim A Muñoz-Álvarez, K. Shinozaki, C. Baumgartner +3 more
2016Journal of Visualized Experiments6 citations Open access
Semantic Scholar
Phase III trial of a 3-weekly versus 5-weekly schedule of S-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOS study.
M. Ryu, E. Baba, K. Lee, N. Boku +16 more
2013Journal of Clinical Oncology6 citations
Semantic Scholar
[mFOLFOX6 for treatment of anal canal cancer with disseminated carcinomatosis of bone marrow--a case report].
M. Yamauchi, Yohei Okamoto, M. Doi, K. Shinozaki
2010Gan to kagaku ryoho. Cancer & chemotherapy6 citations
Semantic Scholar
Occurrence of Immunoglobulin G4-related Disease during Chemotherapy for Advanced Breast Cancer
Yasutoshi Fujii, M. Doi, H. Yamane, T. Morioka +3 more
2020Internal medicine5 citations Open access
Semantic Scholar
REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis.
T. Yoshino, T. Yamanaka, T. Denda, Yasushi Tsuji +14 more
2018Annals of Oncology5 citations Open access
Semantic Scholar
T-ACT (WJOG7112G): A randomized phase II study of weekly paclitaxel ± trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum.
T. Esaki, A. Makiyama, T. Kashiwada, A. Hosokawa +16 more
20175 citations
Semantic Scholar
A Case of Gingival Metastasis from Rectal Cancer in Which Immunohistochemistry and PET-CT Were Useful for the Diagnostic Procedure
M. Yamauchi, K. Shinozaki, M. Doi, T. Nitta +1 more
2014Case Reports in Oncology5 citations Open access
Semantic Scholar
REVIVE study: A prospective observational study in chemotherapy (CTx) after nivolumab (NIVO) therapy for advanced gastric cancer (AGC).
T. Matsushima, Y. Narita, T. Misumi, Y. Sakamoto +16 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Treatment of opioid-induced constipation with naldemedine in patients with cancer: onset of action in a randomized phase 3 trial
T. Murata, N. Katakami, T. Harada, K. Shinozaki +6 more
20164 citations Open access
Semantic Scholar
Retroperitoneal leiomyosarcoma in a female patient with a germline splicing variant RAD51D c.904-2A > T: a case report
Mashu Futagawa, Hideki Yamamoto, M. Kochi, Yusaku Urakawa +8 more
2021Hereditary Cancer in Clinical Practice3 citations Open access
Semantic Scholar
Pre- versus postoperative CAPOX plus bevacizumab (CAPOX-Bev) for resectable liver metastases from colorectal cancer (CLM): A randomized phase II/III trial (HiSCO-01).
Y. Takakura, K. Shinozaki, S. Ikeda, H. Egi +10 more
20203 citations
Semantic Scholar
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases (CLM): A post hoc analysis of the WJOG4407G phase III study.
A. Hosokawa, K. Yamazaki, C. Matsuda, S. Ueda +12 more
2018Annals of Oncology3 citations Open access
Semantic Scholar
Phase 3 study to evaluate the efficacy and safety of naldemedine for the treatment of opioid-induced constipation (OIC) in cancer patients.
T. Harada, N. Katakami, T. Murata, K. Shinozaki +6 more
20163 citations
Semantic Scholar
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G
H. Arai, E. Inoue, K. Yamaguchi, N. Boku +11 more
2021Cancer Medicine2 citations Open access
Semantic Scholar
Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases
A. Hosokawa, K. Yamazaki, C. Matsuda, S. Ueda +12 more
2020Medicine2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Boku×14
Invite
N. Boku — researcher profile on SciRah
I. Hyodo×11
Invite
I. Hyodo — researcher profile on SciRah
T. Esaki×9
Invite
T. Esaki — researcher profile on SciRah
T. Moriwaki×8
Invite
T. Moriwaki — researcher profile on SciRah

×8

Invite

K. Muro — researcher profile on SciRah

Invite

T. Nishina — researcher profile on SciRah

Invite

A. Hosokawa — researcher profile on SciRah

Invite

O. Ebert — researcher profile on SciRah

Invite

S. Woo — researcher profile on SciRah

Invite

T. Yoshino — researcher profile on SciRah

Invite

E. Baba — researcher profile on SciRah

Invite

T. Denda — researcher profile on SciRah